Back
Ashtead Group PLC Vs. Kymera Therapeutics Industry Stock Comparison
Sell
46
ASHTF
Ashtead Group PLC
Last Price:
74.85
Seasonality Move:
12.45%
Buy
62
KYMR
Kymera Therapeutics
Last Price:
46.17
Seasonality Move:
69.6%
Sell
46
Ashtead Group PLC (ASHTF)
is a Sell
Is Ashtead Group PLC a Buy, Sell or Hold?
- The current Ashtead Group PLC [ASHTF] share price is $76.38. The Score for ASHTF is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- ASHTF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $47.65. The Score for KYMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ASHTF Stock Price Chart
What is Ashtead Group PLC's stock price today?
-
The Ashtead Group PLC share price today is $76.38
The current trend is moderately bearish and ASHTF is experiencing buying pressure, which is a positive indicator for future bullish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $47.65
The current trend is moderately bearish and KYMR is experiencing slight selling pressure.
ASHTF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.73 | Buy |
Relative Strength Index (14 RSI): | 54.33 | Buy |
Chaikin Money Flow: | 692 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (74.73 - 77.41) | Buy |
Bollinger Bands (100): | (66.94 - 74.64) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.6 | Buy |
Relative Strength Index (14 RSI): | 52.44 | Buy |
Chaikin Money Flow: | -88534 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.05 - 49.09) | Buy |
Bollinger Bands (100): | (36.61 - 48.91) | Buy |
ASHTF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 76.08 | Buy |
20-day SMA: | 75.72 | Buy |
50-day SMA: | 73.37 | Buy |
200-day SMA: | 70.23 | Buy |
8-day EMA: | 76.13 | Buy |
20-day EMA: | 75.69 | Buy |
50-day EMA: | 73.87 | Buy |
200-day EMA: | 70.27 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.2 | Sell |
20-day SMA: | 46.01 | Buy |
50-day SMA: | 47.06 | Buy |
200-day SMA: | 39.57 | Buy |
8-day EMA: | 47.93 | Sell |
20-day EMA: | 47.19 | Buy |
50-day EMA: | 46.06 | Buy |
200-day EMA: | 39.32 | Buy |
Ashtead Group PLC Earnings Growth & ASHTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.
Ashtead Group PLC Technical Analysis
Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |